preferred drug
Scope
Date
~
-
Travel & Leisure
Seoul reclaims spot as Japanese tourists' top destination after 11 yrs: HIS
Seoul has become the top destination for Japanese tourists for the first time since 2011, according to Japan’s leading travel agency HIS Gro...
Nov 28, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Real estate
Nexon named preferred bidder for 50% of office tower from KTCU
Gaming giant Nexon Co. is set to acquire a 50% stake in the Autoway Tower, an office building in Seoul's Gangnam business district, from the Korean ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
Mezzion Pharma to try again for US FDA approval of drug
South Korea's Mezzion Pharma will seek to get the oral medicine Udenafil to treat side effects from heart surgery, planning to clinical trials in th...
Nov 23, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Sale of Korean dental scanner maker Medit fails
The sale of South Korea's dental scanner manufacturer Medit will undergo a reset as the preferred bidder, a consortium led by GS Holdings and the US...
Nov 14, 2022 (Gmt+09:00)
-
Bio & Pharma
No more ineffective drugs due to resistance
L-Base is a pharmaceutical startup specializing in developing drugs for those who become resistant to existing cancer treatments. This year, the Minis...
Nov 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Moderna to stay ahead in mRNA technology: CSO Melissa Moore
CAMBRIDGE, MA – The COVID-19 coronavirus disease has been a curse for many people and companies around the world over the past couple of years...
Oct 14, 2022 (Gmt+09:00)
-
Bio & Pharma
SillaJen shares jump as exchange maintains listing, allows resumed trade
Shares in South Korea’s scandal-hit biotechnological company SillaJen Inc. soared on Thursday after the local exchange decided to maintain the...
Oct 13, 2022 (Gmt+09:00)
-
Corporate bonds
Korean corporate bond issuance hits 2022 monthly low in September
South Korean corporate bond issuance in September hit a monthly low this year on souring investor sentiment due to interest rate hikes.Corporate bon...
Oct 07, 2022 (Gmt+09:00)
-
Culture & Trends
Average is over; microsegment consumers, professor says
The phrase “Average is over” topped the list of 10 key phrases suggested by a renowned Korean consumer behavior professor to predict 202...
Oct 05, 2022 (Gmt+09:00)
-
Bio & Pharma
Sanofi, Korean biotech Lemonex ink material transfer agreement
South Korean biotech Lemonex Inc. has signed a material transfer agreement (MTA) with global pharmaceutical giant Sanofi S.A. to use the Korean bi...
Sep 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Aerospace & Defense
Korea eyes $3.8 billion in Redback armored vehicle exports to Australia
South Korea is expected to clinch a deal to export more than 5 trillion won ($3.8 billion) worth of armored vehicles to Australia, which is strength...
Aug 31, 2022 (Gmt+09:00)
-
Tech, Media & Telecom
Korean teens prefer TikTok over KakaoTalk, says survey
South Korean teens appear to prefer to do their social networking on TikTok over KakaoTalk, as short-form videos surge in popularity worldwide. ...
Aug 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean bio firms look to pills, patches for people who fear needles
Getting shots of a drug or vaccine over a long period is not easy for many people.That's probably why global biopharmaceutical companies and biotech...
Aug 24, 2022 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare logs record-high Q2 revenue on back of Remsima
Celltrion Healthcare Co., South Korean biopharmaceutical giant Celltrion Inc.’s global marketing affiliate, posted its record-high second-quar...
Aug 17, 2022 (Gmt+09:00)
-
Culture & Trends
MZers become key consumers of ergonomic office chairs, Sidiz says
Ergonomic office chairs are drawing heightened interest from millennials and Generation Zers in South Korea, according to the country’s leadin...
Aug 12, 2022 (Gmt+09:00)
-
Bio & Pharma
TiumBio inks licensing deal with China's Hansoh for endometriosis drug
South Korean biotech TiumBio Co. has signed a technology transfer agreement of its endometriosis and uterine myoma treatment candidate with China&rs...
Aug 10, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Brookfield likely to beat KKR for $800 mn Korean gas facility
Brookfield Asset Management has entered talks with South Korea's SK Materials Airplus Inc. to buy the latter's industrial gas facility, after its pr...
Aug 07, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
Hanwha Aerospace, Hanwha Defense likely to merge
Hanwha, the South Korean chemicals-to-financial conglomerate, has been a key player in the M&A market with a series of conspicuous acquisitions ...
Jul 25, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals signs epilepsy drug deal with Brazil’s Eurofarma
South Korea’s SK Biopharmaceuticals Co. has signed a deal to license out its technology for Cenobamate, an antiepileptic drug, to Brazil&rsquo...
Jul 15, 2022 (Gmt+09:00)
-
Alternative investments
Korean firms eye alternative assets for safer investments, survey finds
South Korean corporates are increasingly eyeing alternative assets seeking downside protection amid interest rate hikes and equity and bond price dr...
Jul 11, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
1 in 4 biotech firms struggles with decreasing cash reserves
South Korea’s biotechnology firms – public and private alike – are facing increasingly negative financial conditions. T...
Jun 26, 2022 (Gmt+09:00)
-
Bio & Pharma
Pharma companies jump into $3 bn pet care market
South Korean pharmaceutical companies are jumping into the animal medicine and diagnostics market to target the rapidly growing pet care market, whi...
Jun 24, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
KG-led consortium named preferred buyer of Ssangyong Motor
A consortium led by chemicals-to-steel conglomerate KG Group has been named the preferred buyer of South Korea’s troubled sport utility vehicl...
May 13, 2022 (Gmt+09:00)
-
Bio & Pharma
LG Chem receives FDA nod for CUE-102 cancer treatment phase 1 trials
LG Chem Life Sciences, the biopharmaceutical unit of LG Chem Ltd., has received the US Food and Drug Administration’s approval for phase 1 cli...
May 13, 2022 (Gmt+09:00)
-
Mergers & Acquisitions
KKR to buy SK’s gas production facility for more than $785 mn
KKR & Co., a global private equity firm, is set to buy South Korean conglomerate SK Group’s industrial gas production facility at slightly...
May 11, 2022 (Gmt+09:00)
-
Real estate
Mirae Asset named preferred bidder for IFC Seoul
Mirae Asset Global Investments Co., an asset management arm of Mirae Asset Financial Group in South Korea, will be in an exclusive talk with Brookfi...
May 11, 2022 (Gmt+09:00)
-
Korean Investors
73% of LPs to ramp up global warehouse investment
Key asset owners of South Korea are eyeing logistics centers and multifamily housing for real estate investing while planning to reduce exposure to ho...
Apr 26, 2022 (Gmt+09:00)
Latest News
- 1 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 2 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 3 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 4 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google
- 5 Kookmin Bank raises $700 mn in forex bonds amid strong demand